Sonorous Neurovascular receives FDA IDE approval for first U.S. pivotal trial of a venous sinus stent to treat pulsatile tinnitus
Sonorous Neurovascular has received FDA IDE approval for the first U.S. pivotal trial of its venous sinus stent in pulsatile tinnitus.